Nanobiotix is a clinical-stage biotechnology company based in France that develops nanoparticle-based products intended to improve cancer treatment. Its main programme uses hafnium oxide nanoparticles injected into tumours to increase the effect of radiotherapy, and it also works on other nanoparticle technologies. Its customers and partners are hospitals, clinicians and pharmaceutical companies involved in oncology research and treatment, and the company operates through research and clinical development rather than large-scale manufacturing.
On this site Nanobiotix appears as a stock on the London Exchange (UK), code 0QAV, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3026 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
31/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-10.4%
From 52-week high-44.8%
MomentumWeak
46/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-26.3%
6-month return-6.4%
12-month, skipping last month73.5%
Stability (higher is calmer)Weak
12/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)78.7%
Worst drawdown, 1 year (smaller is calmer)-60.0%
LiquidityWeak
41/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.32M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 13.12 – 47.60Daily closes, split-adjusted
Signals
50-day average28.89
200-day average28.74
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.91
Technical summary
Daily
Bearish
5 bullish · 2 neutral · 9 bearish
Weekly
Bearish
3 bullish · 1 neutral · 8 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
21.49
Bullish
EMA 10
22.88
Bullish
SMA 20
22.76
Bullish
EMA 20
23.62
Bullish
SMA 50
28.89
Bearish
EMA 50
26.99
Bearish
SMA 100
30.79
Bearish
EMA 100
28.78
Bearish
SMA 200
28.74
Bearish
EMA 200
27.15
Bearish
Oscillators (daily)
RSI (14)
54.22
Neutral
MACD (12, 26)
-1.55
Bearish
Momentum (12)
15.62
Bullish
Stochastic %K (14)
88.73
Bearish
Williams %R (14)
-11.27
Bearish
CCI (20)
82.22
Neutral
Pivot points (classic, last session)
S3
23.47
S2
24.29
S1
25.03
Pivot
25.85
R1
26.59
R2
27.41
R3
28.15
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
